AAAAAA

   
Results: 1-9 |
Results: 9
A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer
Authors: Kalemkerian, GP Ali, MA Luthra, K Wozniak, AJ Valdivieso, M Kraut, MJ
Citation: Gp. Kalemkerian et al., A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer, CANCER INV, 19(3), 2001, pp. 234-238
Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (intergroup trial 0160)
Authors: Rusch, VW Giroux, DJ Kraut, MJ Crowley, J Hazuka, M Johnson, D Goldbeg, M Detterbeck, F Shepherd, F Burkes, R Winton, T Deschamps, C Livingston, R Gandara, D
Citation: Vw. Rusch et al., Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (intergroup trial 0160), J THOR SURG, 121(3), 2001, pp. 472-483
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer
Authors: Krug, LM Miller, VA Kalemkerian, GP Kraut, MJ Ng, KK Heelan, RT Pizzo, BA Perez, W McClean, N Kris, MG
Citation: Lm. Krug et al., Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer, ANN ONCOL, 11(2), 2000, pp. 227-228
A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer
Authors: Ali, MA Kraut, MJ Valdivieso, M Wozniak, AJ Cummings, G Kalemkerian, GP
Citation: Ma. Ali et al., A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer, CANCER INV, 18(1), 2000, pp. 1-5
Antinuclear antibodies as potential markers of lung cancer
Authors: Fernandez-Madrid, F VandeVord, PJ Yang, X Karvonen, RL Simpson, PM Kraut, MJ Granda, JL Tomkiel, JE
Citation: F. Fernandez-madrid et al., Antinuclear antibodies as potential markers of lung cancer, CLIN CANC R, 5(6), 1999, pp. 1393-1400
'Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor-prognosis stage IV breast cancer - A Southwest Oncology Group phase II study
Authors: Ellis, GK Green, S Livingston, RB Kraut, MJ Pierce, HI Paradelo, JC Taylor, SA Martino, S
Citation: Gk. Ellis et al., 'Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor-prognosis stage IV breast cancer - A Southwest Oncology Group phase II study, AM J CL ONC, 22(5), 1999, pp. 446-449
Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer
Authors: Kalemkerian, GP Belzer, K Wozniak, AJ Gaspar, LE Valdivieso, M Kraut, MJ
Citation: Gp. Kalemkerian et al., Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer, LUNG CANC, 25(3), 1999, pp. 175-182
Lung cancer in patients < 50 years of age - The experience of an academic multidisciplinary program
Authors: Gadgeel, SM Ramalingam, S Cummings, G Kraut, MJ Wozniak, AJ Gaspar, LE Kalemkerian, GP
Citation: Sm. Gadgeel et al., Lung cancer in patients < 50 years of age - The experience of an academic multidisciplinary program, CHEST, 115(5), 1999, pp. 1232-1236
Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer
Authors: Ali, MA Kraut, MJ Valdivieso, M Herskovic, AM Du, W Kalemkerian, GP
Citation: Ma. Ali et al., Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer, LUNG CANC, 22(1), 1998, pp. 39-44
Risultati: 1-9 |